Navigation Links
Capitol chemistry: How Congress will alter the science landscape in 2014
Date:1/29/2014

The Congressional agenda for 2014 includes science issues with far-reaching implications for an array of issues including public health, job growth, pharmaceutical research and energy, according to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society. The mid-term elections occurring this fall, however, promise to complicate progress on key legislative efforts, already stymied by a bitter partisan atmosphere.

Among the topics that the article addresses is the modernization of the Toxic Substances Control Act, a law that governs commercial chemicals. In a rare bipartisan effort, policymakers from both sides of the aisle are helping refine legislation, which was introduced last year. As it gains bipartisan momentum, private sector interests are adding friction and could affect the strength of specific provisions. Other article highlights include forecasts for energy bills to address power plant emissions and nuclear waste disposal; science policy that could encourage research and development or make it more difficult; and consumer protection laws affecting dietary supplements and antibiotics.

In addition to bills with the most obvious ties to chemical research and businesses, the article notes that industry experts also must keep a keen eye on intertwined agricultural and international issues as well. For example, the farm bill could include provisions that affect pesticide use, and trade agreements have the potential to boost domestic job growth in the chemical industries.


'/>"/>
Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Stanford expert brings climate change science to heated Capitol Hill
2. Biochemistry: Unspooling DNA from nucleosomal disks
3. 7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
4. Purdue professor to speak before Congress about nanotechnology in brain treatment research
5. ESMO 2012 Congress: A path for medical oncology innovations
6. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
7. International congress on behavior, animal husbandry and animal well-being in Vienna
8. 2016 International Congress of Entomology to be held in Orlando, Florida
9. Madidi conservationist wins award at World Conservation Congress
10. Noteworthy studies at the ESMO 2012 Congress
11. Majority of Americans doubt Congress and White House can avoid fiscal cliff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... , December 22, 2016 SuperCom (NASDAQ: ... secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors ... SuperCom, has been selected to implement and deploy a community-based supportive ... Northern California , further expanding its presence in the ... This new ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
(Date:12/16/2016)... The global wearable medical device market, in terms of value, is ... billion in 2016, at a CAGR of 18.0% during the forecast ... Growth ... devices, launch of a growing number of smartphone-based healthcare apps compatible ... and increasing focus on physical fitness. Furthermore, growing ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical ... spectrum of drug and device development, and Prism Clinical Research , a ... today announced Verified Clinical Trials (VCT) has been selected by both ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
(Date:1/19/2017)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ), ... a live webcast of its Annual Meeting of Shareholders on Tuesday, ... webcast can be accessed from the BD corporate website at ... 2017. ... BD BD is a global medical technology company that is ...
(Date:1/18/2017)... 2017 According to a new market research report "In ... Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global ... 739.9 Million by 2021 from USD 557.1 Million in 2016, growing at a ... ... MarketsandMarkets Logo ...
Breaking Biology Technology: